Increased CSF levels of soluble AXL at diagnosis correlate with poor prognosis in patients affected by amyotrophic lateral sclerosis.
Saved in:
| Title: | Increased CSF levels of soluble AXL at diagnosis correlate with poor prognosis in patients affected by amyotrophic lateral sclerosis. |
|---|---|
| Authors: | Spatafora MG; Cellular and Molecular Neuropharmacology Laboratory, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Dubin J; Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.; Laboratory Medicine, UZ Leuven (University Hospitals Leuven), Leuven, Belgium., Domi T; Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy., Lombardi R; 3rd Neurology Unit-Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy., Cabras P; Cellular and Molecular Neuropharmacology Laboratory, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Dalla Bella E; 3rd Neurology Unit-Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy., Consonni M; 3rd Neurology Unit-Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy., Quattrini A; Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy., Verri M; Cellular and Molecular Neuropharmacology Laboratory, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Lauria G; 3rd Neurology Unit-Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy.; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy., Van Damme P; Department of Neurology, UZ Leuven (University Hospitals Leuven), Leuven, Belgium.; Laboratory of Neurobiology, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium., Poesen K; Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.; Laboratory Medicine, UZ Leuven (University Hospitals Leuven), Leuven, Belgium., Riva N; 3rd Neurology Unit-Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy., Peviani M; Cellular and Molecular Neuropharmacology Laboratory, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy. |
| Source: | Brain communications [Brain Commun] 2026 Mar 30; Vol. 8 (2), pp. fcag086. Date of Electronic Publication: 2026 Mar 30 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-1297 |
|---|---|
| DOI: | 10.1093/braincomms/fcag086 |
